Back to News
Market Impact: 0.05
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
Source: zacks.com
Healthcare & Biotech
The article promotes the iShares U.S. Medical Devices ETF (IHI) for broad exposure to the Healthcare—Medical Devices segment. It notes the ETF is passively managed and was launched on May 1, 2006. No new financial data, catalyst, or market-moving development is provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Palantir patient data tech rejected by many NHS trusts in England
- Yields continue to rattle investors. These sectors are most at risk if rates stay elevated
- After years of U.S. export bans, China plans its own: 40 AI, chip and solar technologies could be restricted
- Sickle cell gene therapies offer new hope, but access remains a major challenge
- Trump’s pharma holdings surged from $1.7 million in 2024 to $56.2 million as drugmakers gained Medicare exemptions, Democrats say
- MapLight Therapeutics CMO Erin Foff sells $124,068 in stock
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Eli Lilly Q4 2025 Earnings: Revenue Surges 43% as Mounjaro and Zepbound Dominate the GLP-1 Market
- Investment Research Software Costs: A 2026 Budget Framework